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Abstract
Background: Human induced pluripotent stem (hiPS) cells have the ability to undergo self-renewal and
differentiation similarly to human embryonic stem (hES) cells. We have recently shown that hES cells under
replication stress fail to activate checkpoint kinase 1 (CHK1). They instead commit to apoptosis, which appears to be
a primary defense mechanism against genomic instability. It is not known whether the failure of CHK1 activation
and activation of apoptosis under replication stress is solely a feature of hES cells, or if it is a feature that can be
extended to hiPS cells.
Methods: Here we generated integration-free hiPS cell lines by mRNA transfection, and characterised the cell lines. To
investigate the mechanism of S phase checkpoint activation, we have induced replication stress by adding excess
thymidine to the cell culture medium, and performed DNA content analysis, apoptosis assays and immunoblottings.
Results: We are showing that hiPS cells similarly to hES cells, fail to activate CHK1 when exposed to DNA replication
inhibitors and commit to apoptosis instead. Our findings also suggest the Ataxia Telangiectasia Mutated pathway
might be responding to DNA replication stress, resulting in apoptosis.
Conclusion: Together, these data suggest that the apoptotic response was properly restored during reprogramming
with mRNA, and that apoptosis is an important mechanism shared by hiPS and hES cells to maintain their genomic
integrity when a replication stress occurs.
Keywords: Induced pluripotent stem cells, Integration-free reprogramming, Checkpoint kinase 1, Apoptosis,
Replication stress, Ataxia telangiectasia and rad3-related, Ataxia telangiectasia mutated, Genomic instability
Background
Human induced pluripotent stem (hiPS) cells have the
ability to undergo self-renewal and differentiation similarly
to human embryonic stem (hES) cells. However, instead of
being derived from embryos, hiPS cells are produced
through reprogramming from somatic cells of any individ-
ual and are therefore the ultimate source for personalized
cells. hiPS cells were initially reprogrammed using retro-
viral vectors overexpressing a set of transcription factors
found expressed at high levels in hES cells (i.e., octamer-
binding transcription factor 3/ 4 (OCT4), sex determining
region Y-box 2 (SOX2), kruppel-like factor 4 (KLF4), and
C-MYC) [1]. However, retroviral vectors leave a footprint
in the resulting induced pluripotent stem (iPS) cells that
could cause insertional mutagenesis and oncogene activa-
tion, which makes them undesirable for clinical applica-
tions. For this reason, integration-free and virus-free
methods have been developed to reduce this risk and open
the way for clinical-grade iPS cell lines. In particular,
mRNA-based reprogramming completely abolishes the
risk of any DNA footprint and allows for efficient and fast
reprogramming [2].
The ataxia telangiectasia and rad3-related (ATR) path-
way is the primary response to replication stress in
tumor models. The ATR complex assembles at stalled
replication fork and activates checkpoint kinase 1
(CHK1). CHK1 then induces a DNA damage response
cascade, resulting in cell cycle arrest, an inhibition of
* Correspondence: C.unger@sheffield.ac.uk
†Equal contributors
1Centre for Stem Cell Biology, Department of Biomedical Science, University
of Sheffield, Western Bank, Sheffield S10 2TN, UK
Full list of author information is available at the end of the article
© 2016 Desmarais et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Desmarais et al. Stem Cell Research & Therapy  (2016) 7:17 
DOI 10.1186/s13287-016-0279-2
origin firing, and a stabilization of replication forks
(reviewed in [3, 4]). Knockout or inhibition of CHK1
during DNA replication stress induces single-stranded
DNA (ssDNA) stretches, DNA damage, and genomic in-
stability [5, 6]. Recently, we have shown that hES cells
under replication stress fail to activate CHK1. They in-
stead commit to apoptosis without forming ssDNA,
which appears to be a primary defense mechanism
against genomic instability [7].
It is not known whether the failure of CHK1 activation
and activation of apoptosis under replication stress is
solely a feature of hES cells, or whether it is a feature
that can be extended to hiPS cells. Given the vast inter-
est for the potential use of hiPS cells in clinical therap-
ies, it is important to know whether hiPS cells are able
to protect themselves against genomic instability in a
similar way to hES cells, knowing that hiPS cells can dif-
fer from hES cells in their epigenetic profiles and in
functionalities [8, 9]. Here we generated integration-free
hiPS cell lines by mRNA transfection to investigate the
mechanism of S-phase checkpoint activation within
those cells.
Materials and methods
Cell lines and treatments
This study employed the Shef5 hES cell line, derived at
the University of Sheffield [10], the CRL-2429 human
fetal foreskin fibroblasts (HFF) and the HCT116 colon
cancer cell line (ATCC, Manassas, VA, USA). Thymidine
(TdR) (2 mM; Sigma, St. Louis, MO, USA) was used to
induce replication stress.
Reprogramming and iPS maintenance
HFF were grown in FBSm media consisting of Dulbec-
co’s modified Eagle’s medium (DMEM) + 10 % fetal bo-
vine serum (FBS) and reprogrammed in a norm-oxygen
environment using a Stemgent mRNA Reprogramming
kit (Stemgent, Cambridge, MA, USA) following the
manufacturer’s guidelines. Briefly, HFF were seeded onto
inactivated human feeders cells in Pluriton™ medium
(Stemgent), followed by daily transfections with modified
mRNA encoding the five transcription factors OCT4,
SOX2, KLF4, CMYC, and LIN28 while suppressing the
intracellular immune response by adding interferon-
binding protein B18R. Successfully reprogrammed col-
onies were selected by morphology and picked mech-
anically for the first three passages, and then
propagated using Collagenase IV. hiPS cells were main-
tained on inactivated mouse embryonic fibroblast feeder
cells in KSR medium (DMEM–F12 supplemented with
20 % KnockOut™ Serum Replacement (Life Technologies,
Carlsbad, CA, USA ), 1 % non-essential amino acids, 1 %
L-glutamine, 0.1 mM beta-mercaptoethanol, 4 ng/ml basic
fibroblast growth factor).
The resulting hiPS cell lines were named mRNA-
induced foreskin fibroblast (MIFF). The MIFF lines used
for checkpoint analysis were between passages 10 and 20
and karyotypically normal (data not shown). MIFF1 and
MIFF3 were registered online (http://hpscreg.eu/).
Immunocytochemistry
Primary and secondary antibodies were diluted in
phosphate-buffered saline + 10 % FBS. Antibodies used
were anti-OCT3/4 (C-10, 1:100; SantaCruz, Santa
Cruz, CA, USA, and concentrated supernatant from
hybridomas anti-stage-specific embryonic antigen
(SSEA)-1 (MC480-1, 1:10 [11]), anti-SSEA-4 (MC813-
70, 1:10 [12]), and anti-TRA-1-81 (1:10 [13]). Images
were taken on the InCell Analyzer platform (GE
Healthcare, Little Chalfont, Buckinghamshire,U.K.).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted using Trizol reagent (Life
Technologies) following the manufacturer’s guidelines. A
high-capacity cDNA reverse transcription kit (Applied
Biosystems, Carlsbad, CA, USA) was used to generate
cDNA. Subsequent RT-PCR reactions were carried out
using Taq DNA polymerase (Life Technologies). Primers
were as follows: beta-actin, forward TGAAGTGT-
GACGTGGACATC and reverse GGAGGAGCAAT-
GATCTTGAT; alpha-fetoprotein (AFP), forward
CGCTGCAAACGATGAAGCAAG and reverse
AATCTGCAATGACAGCCTCAAG; brachyury, forward
CGCATGATCACCAGCCACTG and reverse TTTAA-
GAGCTGTGATCTCCTCG; and paired box 6 (PAX6),
forward AATAACCTGCCTATGCAACCC and reverse
AACTTGAACTGGAACTGACACAC).
Teratoma formation assay
Single iPS cells (5 × 106–8 × 106 cells) detached with
Accutase (Life Technologies) were mixed with Matrigel
and 3 × 105 inactivated MEFs in a total volume of 100 μl.
The cell mix was injected subcutaneously and mice were
sacrificed after 9–12 weeks. Teratomas were dissected,
fixed in formaldehyde, embedded, sectioned, and stained
with hematoxylin and eosin (H & E).
DNA content and apoptosis assay
DNA content was analyzed as described previously [14].
Acquisition of flow cytometric data was carried out with
a CyAn ADP analyzer (Beckman Coulter, High
Wycombe, UK), and FlowJo 7.6 software was used for
analysis (TreeStar Inc., Ashland, OR, USA). AnnexinV
staining was performed according to the manufacturer’s
instructions (BD Bioscience, Franklin Lakes, NJ, USA).
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Immunoblottings
Antibodies and protocols were published previously
[7]. P53S15 was obtained from Cell Signaling (Dan-
vers, MA, USA, no. 9284 s, 1:1000;).
Statistical analysis
Statistical analysis was conducted using JMP (SAS Institute,
Cary, NJ, USA). A one-way analysis of variance was used to
evaluate the variance between groups, and a Student’s t test
was used to evaluate the statistical differences between
control and experimental groups. p <0.05 was considered
significant.
Results
We produced integration-free iPS cell lines from HFFs
as summarized in Fig. 1a, using mRNA encoding five
reprogramming factors, namely OCT4, SOX2, KLF4, C-
MYC, and LIN28, and nuclear green fluorescent protein
Fig. 1 hiPS cells generated with an mRNA-based integration-free method display typical characteristics of hES cells. a Timeline and essential steps
for the reprogramming of human fibroblasts into mRNA-induced iPS cells. Human fibroblasts were plated 1 day before the first transfection in
FBSm media, on a human feeder-coated dish. Cells were transfected daily with synthetic mRNA encoding the factors OCT4, SOX2, KLF4, C-MYC,
and LIN28 in Pluriton™ reprogramming medium plus B18R (all provided by Stemgent) and kept in norm-oxygen (21 %) conditions. iPS colonies
appeared between days 15 and 21, when they were mechanically picked and moved onto feeders in KSR medium. b Morphological changes of
human fibroblasts throughout the reprogramming period in norm-oxygen. Typical fibroblast morphology at the start (day 0), transitioning cells
with epithelial morphology half-way (day 10), until embryonic stem cell-like colonies have formed (day 19). Magnification: 40× (background
images), digital zoom (smaller windows). c hiPS cell lines express typical intracellular and extracellular pluripotency markers. Immunofluorescence
staining with monoclonal antibodies of stem cell markers OCT4, TRA-1-81, and SSEA4 (red) and Hoechst DNA counterstain (blue) shown for iPS cell
lines MIFF1 and MIFF3. Magnification: 40× (background images), digital zoom (smaller windows). d Established hiPS cells are able to differentiate
and induce markers of three germ layers in a 7-day EB differentiation assay. Early ectoderm marker PAX6, mesoderm marker brachyury, and
endoderm marker AFP are upregulated in day 7 EBs, as analyzed by RT-PCR. Nanog, a marker of undifferentiated hES cells, decreases its expression
upon differentiation. Beta-actin is used as a housekeeping gene. e Representative images of H & E-stained microsections of a teratoma generated
after injection of hiPS cells into immunocompromised mice. Teratomas were extracted 9–12 weeks after injection and fixed in formaldehyde
before embedding and sectioning. Sections show the presence of cartilage (mesoderm), intestinal glandular-like structure (endoderm), and
neural tissue (ectoderm), representing derivative of the three germ layers. Magnification: 160×. AFP alpha-fetoprotein, UD undifferentiated
cells, EB embryoid body, FBS fetal bovine serum, hES human embryonic stem, MIFF mRNA-induced foreskin fibroblast, PAX6 paired box 6,
SSEA stage-specific embryonic antigen
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(GFP) as a transfection reporter [2]. Messenger RNA
was transfected daily into fibroblasts until iPS cell col-
onies appeared, between days 15 and 21 (Fig. 1b). hiPS
cell lines were characterized for their expression of stem
cell markers and their ability to differentiate into deriva-
tives of the three germ layers. The undifferentiated MIFF
iPS cell lines expressed characteristic markers of undif-
ferentiated pluripotent stem cells, OCT4, TRA-1-81, and
SSEA4 (Fig. 1c) but not the differentiation marker
SSEA1 (data not shown). When put through an embry-
oid body (EB) differentiation protocol, they upregulated
the expression of differentiation markers, AFP (endo-
derm), brachyury (mesoderm), and PAX6 (ectoderm), in-
dicating their ability to generate derivatives of the three
germ layers (Fig. 1d). Further, in severe combined im-
munodeficiency (SCID) mice, the MIFF lines also
formed teratomas that showed the presence of cartilage
(mesoderm), intestinal glandular-like structure (endo-
derm), and neural tissue (ectoderm) (Fig. 1e). Addition-
ally, we confirmed that MIFF iPS cell lines were
karyotypically normal (46XY) and DNA fingerprinting
established their parental origin from the HFF line (data
not shown).
The apoptotic response following DNA replication
stress was investigated in three iPS cell lines (MIFF1,
MIFF3, and MIFF4). Activation of the S-phase
checkpoint was induced by adding excess TdR to the
culture environment. The propidium iodide (PI) profile
of MIFF3 and MIFF4 showed a significant increase in
the sub-G1 population after 16 hours of TdR, and all
three cell lines showed a significant increase after
24 hours of TdR treatment (Table 1, Fig. 2a, b). Con-
comitant with this increase in the sub-G1 population,
the number of cells in the G1, S, and G2 phases were re-
duced in all three iPS cell lines (Table 1, Fig. 2a). In
MIFF3 cells, an increase in active caspase 3 expression
and an increment in annexinV+/PI− cells in MIFF1 cells
were both indicative of apoptotic cells (Fig. 2c, d). Simi-
larly, Shef5N hES cells showed an increase in active cas-
pase 3 expression after TdR treatment. These data
suggest that iPS cells, like hES cells but unlike somatic
tumor cells, undergo apoptosis after replication stress
but do not sustain a cell cycle arrest.
Next, we analyzed the activation status of the proteins
CHK1, γ histone 2AX (γH2AX), and replication protein
A (RPA), known to be signaling through the ATR path-
way and S-phase checkpoint [3]. All three iPS cell lines
displayed reduced levels of pSer345-CHK1 following
TdR, compared with the levels observed in the HCT116
control cell line (Fig. 3a–c). The low levels of pSer345-
CHK1 were comparable with those observed in Shef5N
(Fig. 3a, b). Despite the absence of CHK1 activation, the
Table 1 Cell cycle distribution of iPS cells treated with thymidine
Thymidine
0 hours 6 hours 16 hours 24 hours 48 hours
MIFF1
Sub-G1 phase 10.7 ± 2.2 18.5 ± 6.1 25.8 ± 12.5 38.5 ± 4.2** 51.1 ± 3.9***
G1 phase 33.2 ± 3.4 44.5 ± 0.6* 38.3 ± 4.2 24.5 ± 5.1 20.3 ± 1.5*
S phase 28.9 ± 1.4 20.2 ± 2.3* 23.7 ± 1.8 29.1 ± 4.8 18.7 ± 4.3*
G2 phase 25.6 ± 2.2 15.7 ± 4.4* 10.6 ± 8.1* 7.4 ± 2.9** 8.7 ± 1.6**
Total 98.3 ± 1.4 99.0 ± 1.5 98.4 ± 0.7 99.5 ± 1.4 98.9 ± 0.6
MIFF3
Sub-G1 phase 11.4 ± 3.5 14.0 ± 5.9 26.7 ± 2.2* 34.4 ± 6.2* 44.5 ± 16.6*
G1 phase 30.3 ± 2.3 41.4 ± 3.8* 31.0 ± 4.3 22.4 ± 1.7 21.0 ± 5.0*
S phase 29.2 ± 0.8 29.1 ± 3.7 30.9 ± 3.1 30.9 ± 2.8 22.5 ± 4.8
G2 phase 27.3 ± 5.0 14.7 ± 0.3* 10.7 ± 1.7* 11.2 ± 4.5* 11.0 ± 8.8*
Total 98.2 ± 0.2 99.2 ± 1.4 99.2 ± 0.6 98.9 ± 0.5 98.9 ± 0.2
MIFF4
Sub-G1 phase 9.7 ± 2.4 16.9 ± 5.9 22.1 ± 1.1* 25.2 ± 1.2* 36.8 ± 8.6*
G1 phase 40.2 ± 8.1 40.1 ± 4.2 38.4 ± 4.5 31.3 ± 6.9 27.0 ± 3.6
S phase 25.7 ± 2.5 26.1 ± 5.6 28.6 ± 2.6 31.4 ± 2.4 22.9 ± 5.7
G2 phase 22.3 ± 7.6 15.0 ± 4.0 9.1 ± 1.2 10.5 ± 5.8 11.9 ± 6.3
Total 97.8 ± 0.4 98.0 ± 0.5 98.1 ± 0.4 98.3 ± 0.1 98.5 ± 0.2
*p <0.05, **p <0.001, ***p <0.0001
iPS induced pluripotent stem, MIFF mRNA-induced foreskin fibroblast
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total CHK1 protein was expressed at constant levels
after TdR treatment.
RPA binds ssDNA and is hyperphosphorylated follow-
ing DNA damage or genetic stress [15], and γH2AX is
phosphorylated at the sites of stalled replication fork
[16]. In U-2-OS osteosarcoma cells, inhibition of CHK1
results in the phosphorylation of RPA and γH2AX [6].
Therefore, we asked whether the absence of CHK1 sig-
naling caused a similar increase in RPA and γH2AX acti-
vation in hiPS cells. We found that TdR did not
significantly induce the hyperphosphorylation of RPA
and nor did it induce the activation of γH2AX in hiPS
cells (Fig. 3b, c), while both were induced in control
HCT116 cells in the presence of a CHK1 inhibitor,
Gö6976 (Fig. 3b).
In some situations, ATR response can be substituted
by the ataxia telangiectasia mutated (ATM) response
(reviewed in [17]). We therefore examined the ATM
pathway in iPS cells, and indeed found a delayed activa-
tion in MIFF1 and MIFF4 cell lines following TdR treat-
ment (Fig. 3d, f ). This was accompanied by a mild
activation of P53 phosphorylation at Ser 15 (Fig. 3d–f ).
This activation could suggest a possible role of the ATM
pathway in replication stress-induced apoptosis.
Discussion
To our knowledge, this is the first study examining the
S-phase checkpoint response in hiPS cells, demonstrat-
ing that while there is a suppression of CHK1 activation,
there is also an increase in apoptosis in response to
DNA replication stress. These results are similar to what
we have described previously in hES cell lines [7].
While CHK1 is expressed, it is only weakly activated
in response to TdR in iPS cells, when compared with the
CHK1 response observed in HCT116 cells. Different
levels of suppression are observed amongst different iPS
cell lines, suggesting that CHK1 phosphorylation is sup-
pressed, but not absent. A similar observation has been
made in hES cells [7]. Moreover, CHK1 can be activated
in hES cells following different types of damage (e.g. ir-
radiation induced) [7, 18], suggesting that the lack of re-
sponse to replication stress could be the result of a
Fig. 2 hiPS cells undergo apoptosis and no cell cycle arrest in response to replication inhibitor. a hiPS cell lines MIFF1, MIFF3, and MIFF4 show an
increase in the sub-G1 fraction after TdR treatment as reflected by stacked PI profiles obtained by flow cytometry at different time points. hiPS
cells show an early accumulation in the S phase but fail to reach G2 phase. b Graph depicting the increasing levels of the sub-G1 fraction
determined from their PI profile, according to the time of TdR treatment, for each cell line MIFF1, MIFF3, and MIFF4. c Western blots showing an
increased activation of caspase 3 protein level following TdR treatment. Beta-actin is presented as the control. Shef5N, a normal hES cell line,
also show this increase in caspase 3 activation, while the somatic cell line HCT116 does not, in response to TdR. d Increased proportions
annexinV+/PI– MIFF1 cells, a marker of apoptosis, after TdR treatment. *p <0.05, **p <0.001, ***p <0.0001. MIFF mRNA-induced foreskin fibroblast,
PI propidium iodide, TdR thymidine
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failure to form the ssDNA that triggers CHK1 activation
in such cells. Our findings also suggest the ATM path-
way might alternatively be responding to DNA replica-
tion stress, resulting in apoptosis.
Most studies reporting CHK1 activation in response to
replication stress in somatic cells have been conducted
in tumor models. Recent studies conducted on normal
cells, notably an immortalized human diploid fibroblast
cell line and an immortalized urothelial cell line, suggest
that the ATR–CHK1 pathway response is delayed or
simply not activated in response to replication stress
[19, 20]. However, in contrast to what is observed in
hES and hiPS cells, these nontumor cell lines rapidly
activate ATM, which results in a cell cycle arrest in the
G1 phase, while apoptosis is not induced [4]. The delay
or absence of ATR–CHK1 response in fibroblast and
urothelial cells, and the similar response in hES/hiPS
cells, might suggest that these cell types process
arrested replication forks using a different mechanism
from that used by tumor cells [4]. More importantly,
these data suggest that somatic cells do not share the
same apoptotic mechanism as hES and iPS cells in re-
sponse to replication stress, and the apoptotic response
was properly restored during reprogramming with mRNA.
Conclusion
Genomic integrity is of primary importance when con-
sidering the use of iPS cells in cellular therapies. While
hiPS can be different on the epigenetic level, or can dif-
fer in their capacity for differentiation, this report sug-
gests that apoptosis is an important mechanism shared
by hiPS and hES cells to maintain their genomic integ-
rity when a replication stress occurs.
Fig. 3 Activation of DNA damage response pathways in iPS cell lines in response to TdR. a MIFF1, b MIFF3, and c MIFF4 iPS cell lines show a
reduced CHK1 activation in western blots, comparable with what is observed in the Shef5N normal hES cell line (b) and in contrast to the strong
activation observed in HCT116 cells (b). In all iPS cell lines, there is a reduced γH2AX phosphorylation compared with that observed in HCT116
treated with the CHK1 inhibitor Gö6976 (b), indicating that DNA damage is not enhanced in these cell lines in response to replication inhibitor
TdR, despite the absence of a clear CHK1 activation. In addition, RPA is not hyperphosphorylated in any iPS cell lines, suggesting that ssDNA
formation is suppressed. In contrast, HCT116 cells treated with the CHK1 inhibitor Gö6976 (b) show a marked hyperphosphorylation of RPA. d
MIFF1 and f MIFF4 activate ATM by phosphorylation of Ser1981 after TdR treatment. This is accompanied by the phosphorylation of P53 at S15 in
MIFF1 (d), MIFF3 (e), and MIFF4 (f). CHK1 checkpoint kinase 1, DMSO dimethyl sulfoxide, γH2AX γ histone 2AX, MIFF mRNA-induced foreskin
fibroblast, RPA replication protein A, TdR thymidine
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